| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |